Egypt's drug regulator issues an emergncy use authorization for the Merck anti-COVID-19 oral drug Molnupiravir and said that five companies will manufacture the drug as a first stage.
Egypt's drug regulator issues an emergency use authorization for Merck's Molnupiravir anti-COVID-19 drug.
